Lumretuzumab (Synonyms:鲁妥珠单抗)
目录号 : KM38879 CAS No. : 1448327-63-6 纯度 : ≥99%
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) 是一种人源化的抗 HER3 (ERBB3) 单克隆抗体。Lumretuzumab 有效抑制 PI3K/AKT 和 MAPK 等关键致癌信号通路的活性。Lumretuzumab 经过糖基工程化优化,可增强抗体依赖性细胞介导的细胞毒性 (ADCC) 作用。Lumretuzumab 可用于研究 HER3 阳性、HER2 低表达的实体肿瘤,特别是乳腺癌。
规格 价格 是否有货 数量
1mg
In-stock
5mg 询价 In-stock
10mg 询价 In-stock
50mg 询价 In-stock
100mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody. Lumretuzumab effectively inhibits the activity of key oncogenic signaling pathways such as PI3K/AKT and MAPK. Lumretuzumab has been optimized through glycosyl engineering to enhance antibody-dependent cell-mediated cytotoxicity (ADCC). Lumretuzumab can be used to study HER3-positive, HER2-low-expressing solid tumors, especially breast cancer.
分子量
146.92 kDa
CAS号
1448327-63-6
中文名称
鲁妥珠单抗
运输条件
Shipping with dry ice.
储存方式
Store at -20˚C 
暂无相关参考文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2